AstraZeneca's COVID-19 Vaccine Candidate Begins Late-stage U.S. Study

Monday, 31 August 2020

AstraZeneca's COVID-19 Vaccine Candidate Begins Late-stage U.S. Study

in published on August 31, 2020 leave a reply
AstraZeneca Plc said on Monday it has begun enrolling adults for a U.S.funded, 30,000subject latestage study of its high profile COVID19 vaccine candidate.

from Top Business News- News18.com https://ift.tt/3biBjsP
Previous Post
Next Post
Rohit

post written by:

0 comments: